Paid Clinical Trials in Iowa City, IA
As of August 2026, 554 paid clinical trials are recruiting in Iowa City, Iowa. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Iowa City offers studies at sites including University of Iowa for conditions such as Acute Myeloid Leukemia, Breast Cancer, Multiple Myeloma, Hearing Loss, Sensorineural. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Iowa City
Trials by drug in Iowa City
Filter results
Newly added in Iowa City
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Antidepressant Therapy for Improved Blood Vessel Health After Preeclampsia
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
510 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Assessment of CCM in HF With Higher Ejection Fraction
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
Pompe Disease Registry Protocol
Top Research Study Locations in Iowa City
Researchers run research studies in Iowa City, IA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Iowa | Hearing Loss, Sensorineural, Multiple Myeloma, Cystic Fibrosis | 190 |
| University of Iowa/Holden Comprehensive Cancer Center | Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, B Acute Lymphoblastic Leukemia | 71 |
| University of Iowa Hospitals and Clinics | Atrial Fibrillation, Carrier State, Chronic Lymphocytic Leukemia | 55 |
| University of Iowa Health Care | COVID-19, Glioblastoma, Major Depression | 43 |
| University of Iowa Hospitals & Clinics | AML With Mutated NPM1, Acute Myeloid Leukemia, Hematologic Malignancy | 20 |
| University of Iowa Hospital and Clinics | Ovarian Cancer, Acute Myeloid Leukaemia (AML), Anesthesia | 10 |
| University of Iowa Stead Family Children's Hospital | Acute Myeloid Leukemia, Anesthesia, Cardiac Arrest | 7 |
| Iowa City VA Health Care System, Iowa City, IA | Chronic Kidney Disease, Atherosclerosis, End-Stage Kidney Disease | 5 |
| The University of Iowa | Immune Thrombocytopenic Purpura (ITP), Abdominal Abscess, Attention Deficit Disorder With Hyperactivity (ADHD) | 4 |
| University of Iowa Children's Hospital | Atrial Arrhythmia, Atrial Tachycardia, Congenital Heart Disease | 4 |
| University of Iowa Hospital | Acute Kidney Injury, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia | 4 |
| Clinical Trial Site | ATTR Amyloidosis, Generalized Myasthenia Gravis, Hereditary Transthyretin-mediated (hATTR) Amyloidosis | 3 |
| Holden Comprehensive Cancer Center | Astrocytoma, IDH-Mutant, Grade 4, Diffuse Hemispheric Glioma, H3 G34-Mutant, Diffuse Midline Glioma (DMG) | 3 |
| Integrative Laboratory of Applied Physiology and Lifestyle Medicine | Adverse Childhood Experiences, Endothelial Dysfunction, Oxidative Stress | 3 |
| University of Iowa Carver College of Medicine | Delirium, Depression, Early Onset Hereditary Spastic Paraplegia | 3 |
| University of Iowa College of Dentistry and Dental Clinics | Dental Pulp Necroses, Gingival Recession, Wound Healing | 3 |
| University of Iowa Healthcare | Cardiovascular Diseases, Cochlear Implantation, Cognitive Impairment, Mild | 3 |
| University of Iowa Medical Center | Atrial Fibrillation, Coronary Artery Disease, Intracerebral Hemorrhage | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Ascendis Investigational Site | Growth Hormone Deficiency | 2 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Neoplasms, Head and Neck | 2 |
| Iowa Bioscience Innovation Facility | Electronic Cigarette Use, Endothelial Dysfunction, Gestational Diabetes Mellitus (GDM) | 2 |
| Research Facility | Carcinoid, Carcinoid Tumor, GEP-NET | 2 |
| Stead Family Children's Hospital | Cardiac Arrest (CA), Deep Venous Thrombosis | 2 |
| The University of Iowa Hospitals & Clinics | Crohn's Disease, Primary Immune Thrombocytopenia (ITP) | 2 |
Active & Upcoming Studies in Iowa City (2026)
Recruiting trials in Iowa City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (176 active studies)
- A Safety Study of 212Pb-Pentixather Radioligand Therapy · EARLY_Phase 1 · Yusuf Menda
- KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line) · Phase 2 · Kumquat Biosciences Inc.
Neurology & pain (33 active studies)
Cardiovascular (28 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure · Boston Scientific Corporation
Diabetes & metabolic (18 active studies)
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes · Phase 3 · Novo Nordisk A/S
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Mental health & behavior (11 active studies)
Pediatric (9 active studies)
- Neonatal Platelet Transfusion Threshold Trial · NICHD Neonatal Research Network
- A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) · Phase 3 · Janssen Research & Development, LLC
Vaccines (4 active studies)
- Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19 · MaxWell Clinic, PLC
- COVID-19 Coagulopathy Extension Study · University of Iowa
Eye & vision (2 active studies)
- Glaucoma Related Quality of Life · Marc Toeteberg-Harms
- MMP-9 Inhibition for Recalcitrant Wet AMD · Phase 2 · University of Iowa
HIV / STI (1 active study)
Common conditions studied in Iowa City
- Acute Myeloid Leukemia (11 active studies)
- Breast Cancer (10 active studies)
- Multiple Myeloma (8 active studies)
- Hearing Loss, Sensorineural (5 active studies)
- Non-Hodgkin Lymphoma (5 active studies)
- Stroke (5 active studies)
Leading research sponsors in Iowa City
- University of Iowa
- National Cancer Institute (NCI)
- Children's Oncology Group
- Novartis Pharmaceuticals
- Anna Stanhewicz, PhD
Frequently asked questions
How many paid clinical trials are currently recruiting in Iowa City?
There are approximately 554 recruiting clinical trials in Iowa City, Iowa listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Iowa City pay participants?
Most recruiting trials in Iowa City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Iowa City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Iowa City?
The most common conditions under active study in Iowa City include Acute Myeloid Leukemia (11), Breast Cancer (10), Multiple Myeloma (8), Hearing Loss, Sensorineural (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Iowa City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Iowa City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Iowa City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Iowa City?
Recruiting research sites in Iowa City include University of Iowa, University of Iowa/Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Iowa City right now?
The largest active categories in Iowa City are Cancer & tumors (176), Neurology & pain (33), Cardiovascular (28). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.